Up­dat­ed: DOJ opens crim­i­nal probe in­to Cas­sa­va over al­le­ga­tions of Alzheimer's drug da­ta ma­nip­u­la­tion — re­port

Months af­ter re­ports of al­le­ga­tions re­gard­ing Cas­sa­va Sci­ences’ lead drug can­di­date for Alzheimer’s emerged, the DOJ may now be rais­ing its head to in­ves­ti­gate the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER